Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype
The Journal of Cardiovascular Aging · 2022 · 2 (3) · 30
DOI: 10.20517/jca.2022.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Cardiovascular Aging, 2022. Verfasst von Leila Rouhi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cardiovascular Genetics, Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA. Die Arbeit wurde bisher 36-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NHLBI NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Introduction
Mutations in the LMNA gene, encoding Lamin A/C (LMNA), are established causes of dilated cardiomyopathy (DCM). The phenotype is typically characterized by progressive cardiac conduction defects, arrhythmias, heart failure, and premature death. DCM is primarily considered a disease of cardiac myocytes. However, LMNA is also expressed in other cardiac cell types, including fibroblasts.
Aim
The purpose of the study was to determine the contribution of the fibroblasts to DCM caused by LMNA deficiency. Methods and Results: The Lmna gene was deleted by crossing the platelet-derived growth factor receptor α-Cre recombinase (Pdgfra-Cre) and floxed Lmna (LmnaF/F) mice. The LMNA protein was nearly absent in ~80% of the cardiac fibroblasts and ~25% of cardiac myocytes in the Pdgfra-Cre:LmnaF/F mice. The Pdgfra-Cre:LmnaF/F mice showed an early phenotype characterized by cardiac conduction defects, arrhythmias, cardiac dysfunction, myocardial fibrosis, apoptosis, and premature death within the first six weeks of life. The Pdgfra-Cre:LmnaWild type/F(LmnaW/F) mice also showed a similar but slowly evolving phenotype that was expressed within one year of age. RNA sequencing of LMNA-deficient and wild-type cardiac fibroblasts identified differential expression of ~410 genes, which predicted activation of the TP53 and TNFA/NFκB and suppression of the cell cycle pathways. In agreement with these findings, levels of phospho-H2AFX, ATM, phospho-TP53, and CDKN1A, markers of the DNA damage response (DDR) pathway, were increased in the Pdgfra-Cre:LmnaF/F mouse hearts. Moreover, expression of senescence-associated beta-galactosidase was induced and levels of the senescence-associated secretory phenotype (SASP) proteins TGFβ1, CTGF (CCN2), and LGLAS3 were increased as well as the transcript levels of additional genes encoding SASP proteins in the Pdgfra-Cre:LmnaF/F mouse hearts. Finally, expression of pH2AFX, a bonafide marker of the double-stranded DNA breaks, was increased in cardiac fibroblasts isolated from the Pdgfra-Cre:LmnaF/F mouse hearts.
Conclusion
Deletion of the Lmna gene in fibroblasts partially recapitulates the phenotype of the LMNA-associated DCM, likely through induction of double-stranded DNA breaks, activation of the DDR pathway, and induction of expression of the SASP proteins. The findings indicate that the phenotype in the LMNA-associated DCM is the aggregate consequence of the LMNA deficiency in multiple cardiac cells, including cardiac fibroblasts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Cardiovascular Genetics, Institute of Molecular Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.
- Department of Cardiovascular Medicine and Jiangxi Key Laboratory of Molecular Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi, China.
- Division of Cardiology, Department of Advanced Biomedical Sciences, Federico II University, Naples 80100, Italy.
- 10x Genomics, San Francisco, CA 94111, USA.
- Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.
ORCID-Profile: Leila Rouhi, Gaelle Auguste, Melis Olcum, Sirisha M Cheedipudi, Cristian Coarfa
Förderung
- NIA NIH HHS
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute
- American Heart Association
Zitieren
APA
Rouhi, L., Auguste, G., Zhou, Q., Lombardi, R., Olcum, M., Pourebrahim, K., Cheedipudi, S. M., Asghar, S., Hong, K., Robertson, M. J., Coarfa, C., Gurha, P., & Marian, A. J. (2022). Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype. The Journal of Cardiovascular Aging, 2(3), 30. https://doi.org/10.20517/jca.2022.14
Vancouver
Rouhi L, Auguste G, Zhou Q, Lombardi R, Olcum M, Pourebrahim K, et al. Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype. The Journal of Cardiovascular Aging. 2022;2(3):30. doi:10.20517/jca.2022.14
BibTeX
@article{Rouhi2022,
author = {Rouhi, Leila and Auguste, Gaelle and Zhou, Qiong and Lombardi, Raffaella and Olcum, Melis and Pourebrahim, Kimia and Cheedipudi, Sirisha M and Asghar, Saman and Hong, Kui and Robertson, Matthew J and Coarfa, Cristian and Gurha, Priyatansh and Marian, Ali J},
title = {Deletion of the Lmna gene in fibroblasts causes senescence-associated dilated cardiomyopathy by activating the double-stranded DNA damage response and induction of senescence-associated secretory phenotype},
journal = {The Journal of Cardiovascular Aging},
year = {2022},
volume = {2},
number = {3},
pages = {30},
doi = {10.20517/jca.2022.14}
}
EUVIMED